Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Tevogen Bio (TVGN) News Today

Tevogen Bio logo
$0.94 +0.03 (+3.54%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$0.92 -0.02 (-1.86%)
As of 08/22/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

TVGN Latest News

Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
August 22 at 12:13 AM  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/tevogen-recognized-in-binje-s-best-health-care-2025-for-advancing-health-equity-and-sustainable-biopharma-1035066857
Tevogen Bio Holdings Inc. Recognized in BINJE's BEST Health Care 2025 for Commitment to Health Equity and Innovation
August 22 at 3:51 PM  |  quiverquant.comQ
Tevogen Recognized in BINJE's BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
August 22 at 3:25 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/22/3137994/0/en/tevogen-recognized-in-binje-s-best-health-care-2025-for-advancing-health-equity-and-sustainable-biopharma.html
Tevogen Bio (NASDAQ:TVGN) Announces Earnings Results
August 21 at 5:28 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tevogen-bio-nasdaqtvgn-announces-earnings-results-2025-08-19/
D. Boral Capital Reiterates Buy Rating for Tevogen Bio (NASDAQ:TVGN)
August 20 at 8:24 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/d-boral-capital-reiterates-buy-rating-for-tevogen-bio-nasdaqtvgn-2025-08-18/
Tevogen finalizes agreement for up to $50M in financing
August 19, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/tevogen-finalizes-agreement-for-up-to-50m-in-financing/ar-AA1KPncp
REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
August 19, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/19/3135984/0/en/repeat-tevogen-bio-enters-into-agreement-for-up-to-50-million-in-financing-to-advance-r-d-and-clinical-development-efforts.html
Tevogen Bio Holdings Inc. Reports Q2 2025 Financial Results with Reduced Loss from Operations and Focus on Growth Strategy
August 19, 2025  |  quiverquant.comQ
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
August 19, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/19/3135929/0/en/tevogen-delivers-stronger-second-quarter-and-first-half-2025-financial-results-with-reduced-expenses-and-growth-momentum.html
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
August 18, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/18/3135353/0/en/tevogen-ceo-donates-personal-shares-to-support-local-law-enforcement.html
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
August 18, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/18/3135343/0/en/tevogen-ceo-donates-personal-shares-to-support-brain-injury-recovery.html
Semper Paratus Acquisition (NASDAQ:TVGN) Stock Price Down 3% - Here's What Happened
August 16, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/semper-paratus-acquisition-nasdaqtvgn-stock-price-down-3-heres-what-happened-2025-08-15/
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
August 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/14/3133804/0/en/tevogen-to-release-internal-asset-valuation-ceo-affirms-assets-are-fully-protected.html
Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
August 13, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/13/3132929/0/en/repeat-tevogen-ai-expands-collaboration-with-databricks-and-microsoft-to-build-the-beta-version-of-its-predictcell-model-with-a-focus-on-oncology.html
Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion
August 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/11/3131185/0/en/tevogen-bio-reaffirms-investor-confidence-with-estimated-asset-value-exceeding-10-billion.html
REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
August 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/11/3131141/0/en/repeat-tevogen-bio-specialty-care-reports-top-line-revenue-forecast-of-nearly-1-billion-in-launch-year-and-cumulative-5-year-estimate-between-18-billion-and-22-billion.html
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
August 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/11/3131110/0/en/tevogen-bio-oncology-reports-top-line-revenue-forecast-of-1-billion-in-launch-year-and-cumulative-5-year-estimate-between-10-billion-and-14-billion-forecasts-for-non-oncology-thera.html
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
August 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/11/3130995/0/en/repeat-tevogen-ceo-affirms-strong-growth-capital-position-and-ai-expansion-in-letter-to-stockholders.html
REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
August 8, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/08/3130256/0/en/repeat-tevogen-sees-significant-institutional-ownership-growth-73-of-holders-increase-positions.html
Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy
August 7, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/07/3129320/0/en/tevogen-receives-1-million-to-accelerate-ai-driven-drug-discovery-remains-well-capitalized-to-execute-growth-strategy.html
Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
August 6, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/06/3128605/0/en/tevogen-sees-significant-institutional-ownership-growth-73-of-holders-increase-positions.html
Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
August 5, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/05/3127752/0/en/tevogen-ai-expands-collaboration-with-databricks-and-microsoft-to-build-the-beta-version-of-its-predictcell-model-with-a-focus-on-oncology.html
Semper Paratus Acquisition (NASDAQ:TVGN) Given Buy Rating at D. Boral Capital
August 5, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/semper-paratus-acquisition-nasdaqtvgn-given-buy-rating-at-d-boral-capital-2025-08-04/
Semper Paratus Acquisition Corporation (NASDAQ:TVGN) Sees Significant Increase in Short Interest
August 2, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/semper-paratus-acquisition-corporation-nasdaqtvgn-sees-significant-increase-in-short-interest-2025-08-01/
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
August 1, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/01/3126090/0/en/tevogen-ceo-affirms-strong-growth-capital-position-and-ai-expansion-in-letter-to-stockholders.html
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
August 1, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/01/3126082/0/en/tevogen-bio-to-accept-1-million-additional-grant-funding-for-ai-expansion.html
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision
July 30, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/30/3124316/0/en/tevogen-highlights-74-insider-ownership-reinforcing-long-term-vision.html
Tevogen.AI Applauds U.S. Government's AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
July 28, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/28/3122693/0/en/Tevogen-AI-Applauds-U-S-Government-s-AI-Action-Plan-Reaffirms-Commitment-to-Accelerating-AI-Innovation-in-Healthcare.html
Semper Paratus Acquisition (NASDAQ:TVGN) Shares Down 2.7% - Should You Sell?
July 24, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/semper-paratus-acquisition-nasdaqtvgn-shares-down-27-should-you-sell-2025-07-24/
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
July 18, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/18/3118124/0/en/tevogen-ai-receives-international-patent-publication-for-ai-technology-predicting-immunologically-active-peptides.html
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
July 17, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/17/3117301/0/en/tevogen-signs-letter-of-intent-for-new-in-house-cell-therapy-manufacturing-facility.html
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
July 16, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/16/3116698/0/en/tevogen-ai-targets-faster-time-to-market-with-ai-powered-patient-matching-following-predictcell-alpha-launch.html
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
July 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/14/3114826/0/en/tevogen-ai-builds-alpha-version-of-predictcell-model-with-microsoft-and-databricks-observes-drastic-time-reduction-in-target-analysis-translating-to-potential-savings-of-billions-i.html
Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
July 10, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/10/3113626/0/en/tevogen-s-new-headquarters-fully-funded-by-ceo-centralizes-r-d-and-ai-teams-to-accelerate-innovation.html
Tevogen Bio Holdings Inc News (TVGN) - Investing.com
July 8, 2025  |  investing.comhttps://www.investing.com/equities/semper-paratus-acquisition-news/10
Semper Paratus Acquisition (NASDAQ:TVGN) Shares Down 2.4% - Here's Why
July 2, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/semper-paratus-acquisition-nasdaqtvgn-shares-down-24-heres-why-2025-07-02/
Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters
June 30, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/30/3107814/0/en/tevogen-ceo-contributes-to-build-out-and-first-year-operations-of-new-headquarters.html
Semper Paratus Acquisition's (TVGN) "Buy" Rating Reaffirmed at D. Boral Capital
June 18, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/semper-paratus-acquisitions-tvgn-buy-rating-reaffirmed-at-d-boral-capital-2025-06-18/
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
June 18, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/18/3101449/0/en/tevogen-updates-on-development-of-ebv-specific-t-cell-therapy-with-support-from-ai-powered-target-discovery.html
Tevogen Bio Expands Headquarters To Support Growth In AI And Generics & Biosimilars Initiatives
June 12, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/tevogen-bio-expands-headquarters-support-growth-ai-and-generics-biosimilars-initiatives
Tevogen Bio Expands Headquarters to Enhance R&D and Operational Efficiency with Support from Microsoft
June 10, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/tevogen-bio-expands-headquarters-enhance-rd-and-operational-efficiency-support-microsoft
Tevogen Bio (NASDAQ:TVGN) Given "Buy" Rating at D. Boral Capital
June 10, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tevogen-bio-nasdaqtvgn-given-buy-rating-at-d-boral-capital-2025-06-10/
Ryan H. Saadi Sells 1,438,206 Shares of Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Stock
June 10, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tvgn-insider-buying-and-selling-2025-06-10/
Insider Selling: Tevogen Bio Holdings Inc. (NASDAQ:TVGN) CEO Sells 1,438,206 Shares of Stock
June 9, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-tevogen-bio-holdings-inc-nasdaqtvgn-ceo-sells-1438206-shares-of-stock-2025-06-09/
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
June 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/09/3095883/0/en/tevogen-expands-headquarters-amid-growth-of-ai-and-generics-biosimilars-initiatives.html
tevogen bio expands office lease in new jersey with key amendment
June 5, 2025  |  investing.comhttps://www.investing.com/news/sec-filings/tevogen-bio-expands-office-lease-in-new-jersey-with-key-amendment-93CH-4078842
Tevogen Bio breidt kantoorruimte uit in New Jersey met belangrijke wijziging
June 4, 2025  |  nl.investing.comhttps://nl.investing.com/news/sec-filings/tevogen-bio-breidt-kantoorruimte-uit-in-new-jersey-met-belangrijke-wijziging-93CH-510893
Tevogen Bio breidt AI-initiatief uit voor ontwikkeling immunotherapie
June 1, 2025  |  nl.investing.comhttps://nl.investing.com/news/company-news/tevogen-bio-breidt-aiinitiatief-uit-voor-ontwikkeling-immunotherapie-93CH-508365
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Sees Significant Drop in Short Interest
June 1, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tevogen-bio-holdings-inc-nasdaqtvgn-sees-significant-drop-in-short-interest-2025-05-31/
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
May 30, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/30/3091170/0/en/tevogen-details-its-artificial-intelligence-initiative-tevogen-ai-proprietary-ai-powered-immunotherapy-with-microsoft-and-databricks-partnerships.html
Get Tevogen Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter.

TVGN Media Mentions By Week

TVGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TVGN
News Sentiment
▼
0.80

0.66
▲
Average
Medical
News Sentiment

TVGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TVGN Articles
This Week
▼
13

4
▲
TVGN Articles
Average Week

Get Tevogen Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:TVGN) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel